J

Johnson & Johnson

Makes prescription drugs and medical devices

Healthcare Economics & Market Access Lead

Corporate StrategyConfirmed live in the last 24 hours
Full-timeChiyoda City, Tokyo, JapanNo salary listed

About the Job

Requirements

  • A bachelor's degree in medicine, pharmacy, public health, health economics, or a science field is required.
  • Approximately seven or more years of professional experience in the medical-device, pharmaceutical, or healthcare industry is required.
  • Practical experience in market access or reimbursement-related work in Japan is required.
  • Experience leading government relations, including with the Ministry of Health, Labour and Welfare, or reimbursement application projects is required.
  • Deep understanding of Japan's healthcare system, reimbursement, and pricing systems is required.
  • Ability to build strategies based on health economics and evidence is required.
  • Business-level Japanese and English communication skills, spoken and written, are required.
  • Ability to prepare documents for government agencies is required.
  • Analytical, problem-solving, and project-management skills are required.
  • High autonomy and cross-functional leadership capability are required.

Responsibilities

  • Establish and oversee the HEMA function in Japan and lead it as the organizational owner.
  • Develop and execute medium- and long-term market access strategies aligned with business strategy.
  • Serve as the accountable leader for market access in Japan.
  • Build internal HEMA processes, governance, and capabilities.
  • Develop and execute reimbursement strategies for new and existing products.
  • Lead reimbursement projects, including new reimbursement listing applications, B2/C category and definition-change cases, and reimbursement price management for existing products.
  • Oversee application materials and evidence packages, including reimbursement application request documents.
  • Lead negotiations and communications with the Ministry of Health, Labour and Welfare and related organizations.
  • Lead impact analyses, response planning, and implementation for revisions to medical service fees.
  • Develop health economics and evidence strategies to support reimbursement and value propositions.
  • Oversee health economic evaluations, including cost-effectiveness and budget-impact analyses, where applicable.
  • Advance evidence-generation strategies including real-world evidence, database studies, and consensus studies.
  • Align Japanese requirements with global and regional HEMA strategies.
  • Build relationships with academic societies, key opinion leaders, industry associations, and government-related stakeholders.
  • Promote a favorable market-access environment through evidence-based value propositions.
  • Participate in industry activities and external forums concerning health economics and reimbursement systems.
  • Collaborate closely with commercial, marketing, medical, regulatory, clinical, and finance teams.
  • Contribute a HEMA perspective to product strategy, launch planning, and lifecycle management.
  • Educate internal stakeholders about Japan's medical-device reimbursement system and policy developments.
  • Design the team organization, develop talent, and manage the team.
  • Manage external vendors and consultants supporting health economics analyses, research, and reimbursement applications.
  • Prioritize projects and optimize resource allocation.

Desired Qualifications

  • A master's degree, MBA, or PhD is preferred.
  • Experience managing an organization or function is preferred.

About the Company

Johnson & Johnson

Makes prescription drugs and medical devices

Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.

Company size
10,001+
Company stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886

Recently Posted Jobs

Explore more opportunities at Johnson & Johnson

See more jobs